DE69111232D1 - 5-benzyl barbitursäurederivate. - Google Patents

5-benzyl barbitursäurederivate.

Info

Publication number
DE69111232D1
DE69111232D1 DE69111232T DE69111232T DE69111232D1 DE 69111232 D1 DE69111232 D1 DE 69111232D1 DE 69111232 T DE69111232 T DE 69111232T DE 69111232 T DE69111232 T DE 69111232T DE 69111232 D1 DE69111232 D1 DE 69111232D1
Authority
DE
Germany
Prior art keywords
acid derivatives
barbituric acid
benzyl
toxicity
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69111232T
Other languages
English (en)
Other versions
DE69111232T2 (de
Inventor
Fardos Naguib
Kouni Mahmoud El
Raymond Panzica
Sungman Cha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brown University Research Foundation Inc
Original Assignee
Brown University Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brown University Research Foundation Inc filed Critical Brown University Research Foundation Inc
Application granted granted Critical
Publication of DE69111232D1 publication Critical patent/DE69111232D1/de
Publication of DE69111232T2 publication Critical patent/DE69111232T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/62—Barbituric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69111232T 1990-04-12 1991-04-12 5-benzyl barbitursäurederivate. Expired - Fee Related DE69111232T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/508,363 US5141943A (en) 1990-04-12 1990-04-12 5-benzyl barbiturate derivatives
PCT/US1991/002522 WO1991016315A1 (en) 1990-04-12 1991-04-12 5-benzyl barbiturate derivatives

Publications (2)

Publication Number Publication Date
DE69111232D1 true DE69111232D1 (de) 1995-08-17
DE69111232T2 DE69111232T2 (de) 1995-12-21

Family

ID=24022452

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69111232T Expired - Fee Related DE69111232T2 (de) 1990-04-12 1991-04-12 5-benzyl barbitursäurederivate.

Country Status (10)

Country Link
US (1) US5141943A (de)
EP (1) EP0526537B1 (de)
JP (1) JP3001972B2 (de)
AT (1) ATE124936T1 (de)
AU (1) AU7776891A (de)
CA (1) CA2080343C (de)
DE (1) DE69111232T2 (de)
DK (1) DK0526537T3 (de)
ES (1) ES2077850T3 (de)
WO (1) WO1991016315A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776838B1 (en) 1987-10-28 2010-08-17 Wellstat Therapeutics Corporation Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
US5470838A (en) * 1987-10-28 1995-11-28 Pro-Neuron, Inc. Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
US5691320A (en) * 1987-10-28 1997-11-25 Pro-Neuron, Inc. Acylated pyrimidine nucleosides for treatment of systemic inflammation and inflammatory hepatitis
US5968914A (en) 1987-10-28 1999-10-19 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
US5736531A (en) 1987-10-28 1998-04-07 Pro-Neuron, Inc. Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides
GB9214720D0 (en) * 1992-07-10 1992-08-19 Wellcome Found Enzyme inhibitors
KR100315890B1 (ko) * 1992-12-08 2002-06-27 마이클 바마트 전신염증및염증성간염치료용피리미딘누클레오티드전구체
AU6087894A (en) * 1993-01-14 1994-08-15 Cell Therapeutics, Inc. Acetal or ketal substituted therapeutic compounds
US5567689A (en) * 1993-08-13 1996-10-22 The Uab Research Foundation Methods for increasing uridine levels with L-nucleosides
US5476855A (en) * 1993-11-02 1995-12-19 Mahmoud H. el Kouni Enzyme inhibitors, their synthesis and methods for use
JP2683297B2 (ja) * 1994-02-28 1997-11-26 スンキョン インダストリーズ カンパニー リミテッド ピリミジンアシクロヌクレオシド誘導体
WO1996001115A1 (en) * 1994-07-01 1996-01-18 Pro-Neuron, Inc. Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
US7198190B2 (en) * 1997-03-12 2007-04-03 Dodge Juhan Identification device having reusable transponder
JPH11279157A (ja) * 1998-03-27 1999-10-12 Hoechst Marion Roussel Kk バルビツール酸誘導体およびそれらからなる骨・軟骨疾患予防・治療薬
CA2333537A1 (en) * 1998-05-26 1999-12-02 Rimma Iliinichna Ashkinazi N-substituted derivatives of 5-oxyiminobarbituric acid
US8314064B2 (en) * 1998-07-31 2012-11-20 Massachusetts Institute Of Technology Uridine administration stimulates membrane production
US20060069061A1 (en) * 1998-07-31 2006-03-30 Dick Wurtman Compositions containing uridine and choline, and methods utilizing same
DK2329829T3 (da) 1998-07-31 2014-07-21 Massachusetts Inst Technology Anveldelse af uridin i kombination med cholin til behandling af neurologiske lidelser
US20070004670A1 (en) * 1998-07-31 2007-01-04 Richard Wurtman Compositions containing citicoline, and methods of use thereof
US8143234B2 (en) * 1998-07-31 2012-03-27 Massachusetts Institute Of Technology Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function
US8518882B2 (en) * 1998-07-31 2013-08-27 Massachusetts Institute Of Technology Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
GB0013655D0 (en) * 2000-06-05 2000-07-26 Prolifix Ltd Therapeutic compounds
DE10110355A1 (de) * 2001-03-03 2002-09-12 Ulrich Walker Bekämpfung von Nebenwirkungen
CN105510850A (zh) * 2007-11-02 2016-04-20 麻省理工学院 尿苷饮食添加顺应性方法及其用途
AU2009223453B2 (en) 2008-03-03 2014-05-01 Tosk, Inc. Methotrexate adjuvants to reduce toxicity and methods for using the same
RU2581467C1 (ru) * 2015-04-06 2016-04-20 Федеральное государственное бюджетное учреждение науки "Институт токсикологии Федерального медико-биологического агентства" Антидот окиси углерода
DE102016011954A1 (de) * 2016-10-07 2018-04-12 Merck Patent Gmbh Barbitursäurederivate als Selbstbräunungssubstanzen
EP4031247A1 (de) * 2019-09-16 2022-07-27 Novartis AG Bifunktionelle abbauprodukte und deren verwendungsverfahren

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282921A (en) * 1964-06-04 1966-11-01 Syntex Corp Halo-deoxynucleosides and processes for the preparation thereof
US3464990A (en) * 1967-02-27 1969-09-02 Hoffmann La Roche Barbituric acid derivatives substituted in the five position
US3755295A (en) * 1969-10-24 1973-08-28 Syntex Corp 1-(2-amino-2-deoxy-{62 -d-ribofuranosyl) pyrimidines and derivatives thereof
US3775397A (en) * 1969-11-12 1973-11-27 Akad Wissenschaften Ddr Novel cytostatic 2',3'-dideoxy-3'-fluoropyrimidine-nucleosides
US3687931A (en) * 1970-03-19 1972-08-29 Syntex Corp Halogenated purine and pyrimidine nucleosides and process therefor
US3817982A (en) * 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
DE2627076A1 (de) * 1976-06-16 1977-12-29 Max Planck Gesellschaft Mittel zur inhibierung des zellwachstums
US4071680A (en) * 1976-12-20 1978-01-31 Hoffmann-La Roche Inc. 5'-Deoxy-5-fluoropyrimidine nucleosides
US4093715A (en) * 1977-04-28 1978-06-06 Research Corporation 5-Iodo-5'-amino-2',5'-dideoxycytidine and the pharmaceutically acceptable salts thereof
US4128639A (en) * 1977-12-14 1978-12-05 Research Corporation Nitrosourea analogs of thymidine
US4210638A (en) * 1978-03-17 1980-07-01 Pcr, Inc. Antiviral composition and method of treating virus diseases
US4230698A (en) * 1978-05-12 1980-10-28 Research Corporation 2-Substituted arabinofuranosyl nucleosides and nucleotides
US4604382A (en) * 1983-01-17 1986-08-05 Research Corporation 3'-amino-2',3'-dideoxycytidine and the pharmacologically acceptable salts thereof
US4681933A (en) * 1986-05-01 1987-07-21 University Of Georgia Research Foundation, Inc. 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents

Also Published As

Publication number Publication date
WO1991016315A1 (en) 1991-10-31
US5141943A (en) 1992-08-25
EP0526537B1 (de) 1995-07-12
EP0526537A1 (de) 1993-02-10
JPH05506240A (ja) 1993-09-16
DE69111232T2 (de) 1995-12-21
ATE124936T1 (de) 1995-07-15
JP3001972B2 (ja) 2000-01-24
DK0526537T3 (da) 1995-10-02
ES2077850T3 (es) 1995-12-01
CA2080343A1 (en) 1991-10-13
AU7776891A (en) 1991-11-11
CA2080343C (en) 2001-10-23

Similar Documents

Publication Publication Date Title
DE69111232T2 (de) 5-benzyl barbitursäurederivate.
DK0545966T3 (da) Phospholipidderivater af nucleosider, deres fremstilling samt deres anvendelse som anti-virale lægemidler
DK0465297T3 (da) 9-Purinylphosphonsyre-derivater
DE69716135T2 (de) In 6-position durch thio substituierte paclitaxele
MX9303711A (es) Nucleosidos de pirimida sustituida que tienen actividad anti-tumoral y anti-viral y composicion farmaceutica que los contiene.
DE60101223D1 (de) Antivirale pyrimidin nucleoside derivate
PT100199A (pt) Combinacao antiviral de nucleosidos e processo para a sua preparacao
DE69908819D1 (de) Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
NL300247I1 (nl) 2-Halogeen-9-(2-desoxy-2-fluor-bêta-D-arabinofuranosyl)-adeninenucleosiderivaten.
DK0805683T3 (da) 5-fluor-2',3'-umættet-pyrimidinnukleosider
PT1066269E (pt) Derivados de 1,3,5-triazina trissubstrituidos para o tratamento de infeccoes por hiv
ES2083668T5 (es) Combinaciones antiviricas que contienen analogos de nucleosido.
ATE137242T1 (de) Kovalente-ther lipidnukleosid-konjugate
YU13396A (sh) N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima
ATE205850T1 (de) Behandlung der toxischen wirkung von chemotherapeutischen und antiviralen wirkstoffen mit acylierten pyrimidinnukleosiden
ES2074719T3 (es) Derivados de nucleosido de pirimidina.
FR2687678B1 (fr) Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2686513B1 (fr) Compositions pharmaceutiques aqueuses de cromoglycate sodique.
PT1102594E (pt) Utilizacao de cloreto de sodio para reduzir a toxicidade gastrointestinal de derivados de camptotecina
ES2104917T3 (es) Bis-naftalimidas que contienen engarces amido y tioamido como agentes anticancerosos.
ATE38677T1 (de) Derivate von cyanoimidazol-nukleosiden.
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
NO913659L (no) Hemming av hiv ved anvendelse av synergistiske kombinasjoner av nukleosidderivater.
DE69617031D1 (de) Pyrimidin nukleosid derivate
OA08742A (fr) Dérivés de pyrimidine.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee